NASDAQ : PYPD
PolyPid Ltd. — Financial statements
Healthcare · Biotechnology · Israel
Last price 5.39 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 109.48M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 8.24M | 9.16M | 5.22M | 6.72M | 10.90M | 12.59M |
| Research & Development | 23.36M | 23.81M | 22.81M | 16.15M | 27.99M | 30.55M |
| Operating Expenses | 31.59M | 32.97M | 28.03M | 22.87M | 38.89M | 43.15M |
| Operating Income | -31.59M | -32.97M | -28.03M | -22.87M | -38.89M | -43.15M |
| Interest Expense | -187.00K | -874.00K | -1.51M | -1.62M | -1.02M | |
| Interest & Investment Income | 555.00K | 517.00K | 442.00K | 548.00K | 267.00K | 468.00K |
| Currency Exchange Gain (Loss) | -326.00K | -326.00K | 113.00K | 33.00K | 532.00K | 44.00K |
| Other Non Operating Income (Expenses) | -2.00K | -2.00K | 4.00K | 108.00K | -316.00K | 32.00K |
| EBT Excluding Unusual Items | -31.55M | -33.65M | -28.98M | -23.80M | -39.43M | -42.60M |
| Other Unusual Items | -512.00K | |||||
| Pretax Income | -31.55M | -34.16M | -28.98M | -23.80M | -39.43M | -42.60M |
| Income Tax Expense | -53.00K | 5.00K | 42.00K | 69.00K | 129.00K | |
| Net Income | -31.50M | -34.17M | -29.02M | -23.86M | -39.56M | -42.60M |
| Net Income to Common | -31.50M | -34.17M | -29.02M | -23.86M | -39.56M | -42.60M |
| Shares Outstanding (Basic) | 21.34M | 16.35M | 5.91M | 1.40M | 647.56K | 624.05K |
| Shares Outstanding (Diluted) | 21.34M | 16.35M | 5.91M | 1.40M | 647.56K | 624.05K |
| EPS (Basic) | -1.48 | -2.09 | -4.91 | -16.99 | -61.09 | -68.27 |
| EPS (Diluted) | -1.48 | -2.09 | -4.91 | -16.99 | -61.09 | -68.27 |
| Free Cash Flow | -29.41M | -28.09M | -22.04M | -17.43M | -36.08M | -35.38M |
| Free Cash Flow Per Share | -1.38 | -1.72 | -3.73 | -12.41 | -55.72 | -56.69 |
| EBITDA | -30.12M | -31.51M | -26.41M | -21.05M | -37.17M | -42.03M |
| D&A For EBITDA | 1.48M | 1.46M | 1.62M | 1.82M | 1.72M | 1.12M |
| EBIT | -31.59M | -32.97M | -28.03M | -22.87M | -38.89M | -43.15M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 6.56M | 6.40M | 15.64M | 5.31M | 8.55M | 9.82M |
| Short-Term Investments | 6.53M | 4.04M | 22.38M | |||
| Cash & Short-Term Investments | 6.56M | 12.93M | 15.64M | 5.31M | 12.59M | 32.20M |
| Other Receivables | 605.00K | 166.00K | 96.00K | 239.00K | 596.00K | |
| Receivables | 605.00K | 166.00K | 96.00K | 239.00K | 596.00K | |
| Inventory | 1.36M | 1.11M | ||||
| Prepaid Expenses | 757.00K | 363.00K | 330.00K | 352.00K | 552.00K | 1.45M |
| Restricted Cash | 207.00K | 193.00K | 168.00K | 300.00K | 511.00K | 397.00K |
| Other Current Assets | 27.00K | 268.00K | 10.00K | 298.00K | 162.00K | |
| Total Current Assets | 8.89M | 15.23M | 16.57M | 6.07M | 14.19M | 34.81M |
| Property, Plant & Equipment | 6.02M | 6.77M | 8.37M | 9.22M | 11.68M | 8.76M |
| Other Long-Term Assets | 327.00K | 311.00K | 277.00K | 87.00K | 99.00K | 663.00K |
| Total Assets | 15.23M | 22.31M | 25.22M | 15.37M | 25.97M | 44.23M |
| Accounts Payable | 1.66M | 2.86M | 2.41M | 772.00K | 1.14M | 4.14M |
| Accrued Expenses | 3.65M | 2.73M | 2.54M | 1.95M | 2.41M | 3.67M |
| Current Portion of Long-Term Debt | 988.00K | 6.79M | 4.00M | 4.02M | ||
| Current Portion of Leases | 1.29M | 1.16M | 919.00K | 540.00K | 959.00K | |
| Current Unearned Revenue | 269.00K | |||||
| Other Current Liabilities | 8.00K | 23.00K | 18.00K | 16.00K | 5.00K | |
| Total Current Liabilities | 6.60M | 7.74M | 12.68M | 7.29M | 8.55M | 8.08M |
| Long-Term Debt | 634.00K | 6.38M | 7.57M | |||
| Long-Term Leases | 282.00K | 647.00K | 1.28M | 857.00K | 1.17M | |
| Long-Term Unearned Revenue | 2.55M | 2.55M | 2.55M | 2.55M | 2.55M | |
| Other Long-Term Liabilities | 413.00K | 400.00K | 396.00K | 398.00K | 294.00K | 199.00K |
| Total Liabilities | 9.85M | 11.33M | 17.54M | 17.47M | 20.14M | 8.28M |
| Additional Paid-In Capital | 322.46M | 312.47M | 275.01M | 236.21M | 220.27M | 210.85M |
| Retained Earnings | -317.08M | -301.50M | -267.33M | -238.31M | -214.44M | -174.89M |
| Total Common Equity | 5.39M | 10.97M | 7.68M | -2.10M | 5.83M | 35.96M |
| Shareholders' Equity | 5.39M | 10.97M | 7.68M | -2.10M | 5.83M | 35.96M |
| Total Liabilities & Equity | 15.23M | 22.31M | 25.22M | 15.37M | 25.97M | 44.23M |
| Total Debt | 1.57M | 2.80M | 9.62M | 11.78M | 13.73M | |
| Net Cash (Debt) | 4.99M | 10.14M | 6.02M | -6.47M | -1.14M | 32.20M |
| Net Cash Per Share | 0.23 | 0.62 | 1.02 | -4.61 | -1.75 | 51.60 |
| Filing Date Shares Outstanding | 20.31M | 19.08M | 10.19M | 4.80M | 727.84K | 625.22K |
| Total Common Shares Outstanding | 20.31M | 18.20M | 10.19M | 1.65M | 661.73K | 625.22K |
| Working Capital | 2.28M | 7.49M | 3.89M | -1.22M | 5.64M | 26.73M |
| Book Value Per Share | 0.27 | 0.60 | 0.75 | -1.27 | 8.81 | 57.52 |
| Tangible Book Value | 5.39M | 10.97M | 7.68M | -2.10M | 5.83M | 35.96M |
| Tangible Book Value Per Share | 0.27 | 0.60 | 0.75 | -1.27 | 8.81 | 57.52 |
| Machinery | 9.40M | 8.97M | 8.91M | 8.72M | 6.99M | |
| Leasehold Improvements | 6.57M | 6.52M | 6.50M | 6.50M | 6.02M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -31.50M | -34.17M | -29.02M | -23.86M | -39.56M | -42.60M |
| Depreciation & Amortization | 1.48M | 1.46M | 1.62M | 1.82M | 1.72M | 1.12M |
| Stock-Based Compensation | 3.44M | 4.85M | 2.82M | 3.39M | 4.31M | 4.75M |
| Other Operating Activities | -133.00K | 725.00K | 697.00K | 1.53M | 289.00K | |
| Change in Inventory | -1.36M | -1.11M | ||||
| Change in Accounts Payable | -1.26M | 180.00K | 1.64M | -369.00K | -3.10M | 2.22M |
| Change in Unearned Revenue | 2.55M | |||||
| Change in Other Net Operating Assets | 331.00K | 179.00K | 279.00K | 259.00K | -530.00K | 2.13M |
| Operating Cash Flow | -29.00M | -27.88M | -21.96M | -17.24M | -34.32M | -32.39M |
| Capital Expenditures | -402.00K | -210.00K | -76.00K | -196.00K | -1.77M | -2.99M |
| Investment in Securities | 12.01M | -6.49M | -254.00K | 4.00M | 18.34M | 39.89M |
| Investing Cash Flow | 11.60M | -6.70M | -330.00K | 3.80M | 16.57M | 36.90M |
| Long-Term Debt Issued | 11.71M | |||||
| Total Debt Issued | 11.71M | |||||
| Long-Term Debt Repaid | -6.38M | -3.32M | -2.62M | -402.00K | ||
| Net Debt Issued (Repaid) | -5.75M | -6.38M | -3.32M | -2.62M | 11.31M | |
| Issuance of Common Stock | 13.20M | 32.83M | 38.76M | 9.49M | 4.75M | 1.03M |
| Other Financing Activities | -1.09M | -1.09M | -3.02M | 3.10M | 366.00K | |
| Financing Cash Flow | 6.36M | 25.37M | 32.42M | 9.98M | 16.43M | 1.03M |
| Net Cash Flow | -10.86M | -9.21M | 10.12M | -3.46M | -1.31M | 5.55M |
| Free Cash Flow | -29.41M | -28.09M | -22.04M | -17.43M | -36.08M | -35.38M |
| Free Cash Flow Per Share | -1.38 | -1.72 | -3.73 | -12.41 | -55.72 | -56.69 |
| Levered Free Cash Flow | -17.36M | -15.80M | -12.03M | -10.27M | -24.18M | -18.78M |
| Unlevered Free Cash Flow | -17.25M | -15.25M | -11.09M | -9.26M | -23.54M | -18.78M |
| Cash Interest Paid | 557.00K | 557.00K | 950.00K | 1.04M | 734.00K | |
| Cash Income Tax Paid | 5.00K | 5.00K | 3.00K | 18.00K | 8.00K | |
| Change in Working Capital | -2.29M | -747.00K | 1.92M | -110.00K | -1.08M | 4.35M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 110.09M | 72.19M | 20.68M | 6.28M | 13.71M | 107.66M |
| Enterprise Value | 105.10M | 57.74M | 21.17M | 7.97M | 7.08M | 66.07M |
| Last Close Price | 5.42 | 4.34 | 3.04 | 3.80 | 20.93 | 172.20 |
| PB Ratio | 20.43 | 6.58 | 2.69 | -3.00 | 2.35 | 2.99 |
| P/TBV Ratio | 20.43 | 6.58 | 2.69 | 2.35 | 2.99 | |
| Debt / Equity Ratio | 0.29 | 0.26 | 1.25 | -5.62 | 2.35 | |
| Net Debt / Equity Ratio | -0.93 | -0.92 | -0.78 | -3.09 | 0.20 | -0.90 |
| Net Debt / EBITDA Ratio | 0.17 | 0.32 | 0.23 | -0.31 | -0.03 | 0.77 |
| Net Debt / FCF Ratio | 0.17 | 0.36 | 0.27 | -0.37 | -0.03 | 0.91 |
| Quick Ratio | 0.99 | 1.75 | 1.25 | 0.74 | 1.50 | 4.06 |
| Current Ratio | 1.35 | 1.97 | 1.31 | 0.83 | 1.66 | 4.31 |
| Return on Equity (ROE) | -243.59% | -366.29% | -1,038.73% | -1,278.60% | -189.32% | -78.36% |
| Return on Assets (ROA) | -74.62% | -86.71% | -86.31% | -69.14% | -69.24% | -44.91% |
| Return on Capital Employed (ROCE) | -366.10% | -226.30% | -223.50% | -282.80% | -223.30% | -119.30% |
| Earnings Yield | -27.24% | -47.33% | -140.32% | -379.80% | -288.53% | -39.57% |
| FCF Yield | -26.71% | -38.91% | -106.56% | -277.42% | -263.20% | -32.86% |
| Buyback Yield / Dilution | -121.57% | -176.55% | -321.04% | -116.87% | -3.77% | -95.37% |